Titlebook: Biomarkers and Mental Illness; It’s Not All in the Paul C. Guest Book 2017 Springer International Publishing AG 2017 psychiatric.disorder.

cogent

hypotension

為寵愛

預(yù)定

Assemble

Psychiatric Disorders as “Whole Body” Diseases the brain, but elsewhere in the body. This chapter will briefly cover the history of physiological models of psychopathology with respect to what we now call schizophrenia, the major mood disorders and other psychiatric Illnesses. Over the past 60 years, most historical narratives have focussed on

木訥

Treatment of Psychiatric Disorders: Time for a Paradigm Change?pter introduces the ideas and anticipated benefits of a shift to more individualized or personalized medicine approaches in the identification and treatment of patients with psychiatric disorders (more detailed information is given in Chap. .). This shift will involve the use of biomarkers for bette

獨(dú)裁政府

LIMN

Schizophrenia and the Mind–Body Connectionting individuals with schizophrenia. Inaccurate diagnoses and inadequate treatment will not only hurt the patients but it will also have a negative impact on the patients’ families, society in general, and on cost management of the healthcare services. This chapter also provides details on recent ad

amenity

Progress for Better Treatment of Depressiond by simply improving our understanding of the underlying disease mechanisms. Several studies in the area of depression have now shown that particular pathways in the body are perturbed, including neurotransmitters, the immune system and hormonal networks. Development of biomarkers and disease model

稱贊

The Special Case of Bipolar Disorderlopment of other medical complications due to medication side effects. There have now been a number of biomarker-based investigations which have been carried out in attempts to increase our knowledge of this disease to help tackle the complications of diagnosis and shed new light on potential newer